Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial

Standard

Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial. / VEGA Study Group.

в: The Lancet Gastroenterology and Hepatology, Том 8, № 4, 01.04.2023, стр. 307-320.

Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование

BibTeX

@article{a1dad10e165b405dbf65790c4ac09487,

title = "Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial",

author = "{VEGA Study Group} and Feagan, {Brian G} and Sands, {Bruce E} and Sandborn, {William J} and Matthew Germinaro and Marion Vetter and Jie Shao and Shihong Sheng and Jewel Johanns and Juli{\'a}n Pan{\'e}s and Alexander Tkachev and Dilara Kalimullina and Robert Petryka and Marina Osipenko and Nataliia Tsarynna and Leonid Bilianskyi and Dariusz Kleczkowski and Andrii Yurkiv and Marek Woynarowski and Orest Abrahamovych and Olha Ivanishyn and Grazyna Rydzewska and Jaroslaw Kierkus and Elina Petrova and Olga Vasilevskaya and Halyna Afanasieva and Carlos Francesconi and Jaroslaw Leszczyszyn and Elena Bunkova and Dmitry Platonov and Olena Datsenko and Oleksii Gridnyev and Ihor Hospodarsky and Liudmyla Prystupa and Mykola Stanislavchuk and Anatoly Pershko and Oksana Shchukina and Vladimir Simanenkov and Oleksandr Golovchenko and William Holderman and Juan Lasa and Jakob Begun and {de Lourdes de Abreu Ferrari}, Maria and Pedro Lopez and Andrey Obrezan and Shiraz Farooq and Felix Tiongco and Abel Novillo and Emiliano Tron and Finlay Macrae and Rupert Leong",

year = "2023",

month = apr,

day = "1",

doi = "10.1016/s2468-1253(22)00427-7",

language = "English",

volume = "8",

pages = "307--320",

journal = "The Lancet Gastroenterology and Hepatology",

issn = "2468-1253",

publisher = "Elsevier",

number = "4",

}

RIS

TY - JOUR

T1 - Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial

AU - VEGA Study Group

AU - Feagan, Brian G

AU - Sands, Bruce E

AU - Sandborn, William J

AU - Germinaro, Matthew

AU - Vetter, Marion

AU - Shao, Jie

AU - Sheng, Shihong

AU - Johanns, Jewel

AU - Panés, Julián

AU - Tkachev, Alexander

AU - Kalimullina, Dilara

AU - Petryka, Robert

AU - Osipenko, Marina

AU - Tsarynna, Nataliia

AU - Bilianskyi, Leonid

AU - Kleczkowski, Dariusz

AU - Yurkiv, Andrii

AU - Woynarowski, Marek

AU - Abrahamovych, Orest

AU - Ivanishyn, Olha

AU - Rydzewska, Grazyna

AU - Kierkus, Jaroslaw

AU - Petrova, Elina

AU - Vasilevskaya, Olga

AU - Afanasieva, Halyna

AU - Francesconi, Carlos

AU - Leszczyszyn, Jaroslaw

AU - Bunkova, Elena

AU - Platonov, Dmitry

AU - Datsenko, Olena

AU - Gridnyev, Oleksii

AU - Hospodarsky, Ihor

AU - Prystupa, Liudmyla

AU - Stanislavchuk, Mykola

AU - Pershko, Anatoly

AU - Shchukina, Oksana

AU - Simanenkov, Vladimir

AU - Golovchenko, Oleksandr

AU - Holderman, William

AU - Lasa, Juan

AU - Begun, Jakob

AU - de Lourdes de Abreu Ferrari, Maria

AU - Lopez, Pedro

AU - Obrezan, Andrey

AU - Farooq, Shiraz

AU - Tiongco, Felix

AU - Novillo, Abel

AU - Tron, Emiliano

AU - Macrae, Finlay

AU - Leong, Rupert

PY - 2023/4/1

Y1 - 2023/4/1

U2 - 10.1016/s2468-1253(22)00427-7

DO - 10.1016/s2468-1253(22)00427-7

M3 - Article

VL - 8

SP - 307

EP - 320

JO - The Lancet Gastroenterology and Hepatology

JF - The Lancet Gastroenterology and Hepatology

SN - 2468-1253

IS - 4

ER -

ID: 116232542